We also support Hindi language, do you want change to it?
हम यह भी हिन्दी भाषा का समर्थन है, आप इसे करने के लिए परिवर्तन करना चाहते हैं?
Yes(ह)We also support Punjabi language, do you want change to it?
ਸਾਨੂੰ ਇਹ ਵੀ ਪੰਜਾਬੀ ਭਾਸ਼ਾ ਨੂੰ ਸਹਿਯੋਗ ਹੈ, ਤੁਹਾਨੂੰ ਇਸ ਨੂੰ ਕਰਨ ਲਈ ਤਬਦੀਲੀ ਚਾਹੁੰਦੇ ਹੋ?
Yes(ਜ)We also support Bengali language, do you want change to it?
আমরা বাংলা ভাষা সমর্থন, আপনি এটি পরিবর্তন করতে চান?
Yes(হ)We also support Burmese language, do you want change to it?
ငါတို့သည်လည်း, မြန်မာဘာသာစကားကိုထောကျပံ့သငျသညျကအပြောင်းအလဲလိုသလဲ
Yes(ဟုတ်ကဲ့)We also support Nepali language, do you want change to it?
हामी पनि नेपाली भाषा समर्थन, तपाईं यसलाई परिवर्तन गर्न चाहनुहुन्छ?
Yes(ह)We also support Tagalog language, do you want change to it?
Sinusuportahan din namin ang Tagalog wika, ang gusto mong pagbabago dito?
Yes(oo)We also support Malay language, do you want change to it?
Kami juga menyokong bahasa Melayu, adakah anda mahu perubahan kepadanya?
Yes(yes)We also support Indonesian language, do you want change to it?
Kami juga mendukung bahasa Indonesia, apakah Anda ingin perubahan untuk itu?
Yes(Iya)We also support Thai language, do you want change to it?
นอกจากนี้เรายังสนับสนุนภาษาไทย, คุณต้องการที่เปลี่ยนแปลงไปได้หรือไม่
Yes(ใช่)
HKEx revealed on September 12th that AIM Vaccine Co., Ltd., submitted an IPO application to the main board of the HKEx, with Goldman, CICC, China Securities International and Macquarie Group as its co-sponsors.
In last week’s VC news, pharmaceutical firm Stemirna Therapeutics raises roughly $188 million for COVID vaccine trials, Xiaomi-backed fund invests in autonomous driving startup Zongmu Technology shortly after the company announced a foray into the EV market, supply chain information startup Xforceplus closes $200 million Series C round.
In last week’s VC news: Shenzhen Tengyin raises roughly $15 million in a Series A+ round, EdiGene bags $62 million, while Liaye, founded by former Baidu employees, raises $50 million.
The Chinese government has granted conditional approval to its first homegrown coronavirus vaccine developed by state-owned pharmaceutical giant Sinopharm, health officials announced Thursday.